Price Match Not Guaranteed

Healthcare pricing in America is broken and patients are done waiting for it to be fixed. Across the country, negotiated rates vary wildly, and the data shows that the most expensive hospitals often don’t deliver the highest quality care. This mismatch has pushed consumers to take matters into their own hands, increasingly embracing cash-pay and DTC options especially for high demand medications like GLP-1s to access treatment faster and at more predictable prices. As hospitals experiment with new pricing models such as bundled payments, subscription based primary care, and direct contracting with employers, we may be getting close to understanding what care truly costs and what it’s worth. With new federal rules set to bring real-time drug pricing and prior auth transparency to the point of care, and tariff pressure on manufacturers to more directly justify costs, the industry has a rare opportunity to realign, price, value and trust and begin building a system that patients can navigate with confidence.